The FDA created a workaround this week that effectively undercuts the $375,000 price tag of a drug that became the poster child for concerns about the pharmaceutical industry
The US Food and Drug Administration created a workaround this week that effectively undercuts the $375,000 price tag of a drug that became the poster child for concerns about the pharmaceutical industry.
The FDA announced Monday that it was approving a separate drug for pediatric patients with a rare, painful neuromuscular disease called Lambert-Eaton myasthenic syndrome, also known as LEMS. The disease weakens and fatigues muscles, causing agonizing pain to the point at which patients struggle to walk. The move sparked celebration in the LEMS community and tanked the stock of Catalyst Pharmaceuticals, maker of the $375,000 drug, called Firdapse.
"Jacobus Pharmaceuticals has taken care of so many LEMS patients over the years through their compassionate use program, and they really deserved this approval," she said.Catalyst spokesman David Schull said the company remains"focused on its continued launch of Firdapse to get this medicine to patients in need, including the many who had no access to any treatment prior to the FDA approval of the drug.
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA: Here Are The New Warnings About Sleeping Pills Like Ambien, Lunesta, Sonata'These incidents can occur after the first dose of these sleep medicines or after a longer period of treatment, and can occur in patients without any history of these behaviors and even at the lowest recommended doses,' according to FDA Acting Commissioner Ned Sharpless, M.D.
Read more »
Sanofi’s Dengue Vaccine Gets FDA ApprovalSanofi dengue vaccine was approved in the U.S., the first treatment cleared by American regulators to protect against the mosquito-borne viral infection.
Read more »
Walmart raising tobacco purchase age to 21Walmart outlined steps to prevent minors from buying tobacco products in a letter to the FDA.
Read more »
FDA: People are accidentally killing themselves on Sonata, Ambien. Warning labels are neededThe FDA will require drugmakers of popular sleeping pills to add warning labels after reports of injury and death in patients who took the drugs.
Read more »
FDA allows sale of breast implant linked to cancer, strengthens warningsDespite an outcry from women to ban a particular type of breast implant associated with a rare cancer, the sale of those implants will be allowed in the United States, the Food and Drug Administration announced Thursday.
Read more »
FDA Won’t Ban Certain Breast Implants Despite Cancer ConcernsThe Food and Drug Administration says it doesn’t believe breast implants—which some women say have caused them a range of health problems, from pain to a rare form of cancer—meet the banning standard.
Read more »
FDA won’t ban breast implants linked to cancer at this time
Read more »
Some breast implants may get 'black box' warning, FDA saysAlmost one month after an emotional hearing on breast implant safety, the FDA announced it would not ban textured breast implants, which have been linked to a type of lymphoma.
Read more »